Investors Harmed by Hims & Hers Health, Inc. Encouraged to Join Class Action Lawsuit

On July 10, 2025, The Gross Law Firm announced important information for shareholders of Hims & Hers Health, Inc. (NYSE: HIMS). Individuals who acquired shares of the company between April 29, 2025, and June 23, 2025, and subsequently faced financial losses, are urged to reach out regarding a pending class action lawsuit.

Understanding the Case

The lawsuit alleges that the company misled shareholders by issuing false and/or misleading statements and failing to disclose significant risks involved with its business practices. It is claimed that Hims was involved in the deceptive promotion and sale of unauthorized, knockoff versions of Wegovy®, jeopardizing patient safety. As a result, stakeholders were misled about the company’s collaborations with significant partners, particularly with Novo Nordisk, leading to misleading optimism about its operational health and future prospects.

Shareholders are strongly encouraged to register their details with the firm to monitor the case's progression. While becoming a lead plaintiff is an opportunity, it’s not mandatory for shareholders looking to participate in the recovery process. Registration acts as a protective measure, ensuring that investors receive crucial updates throughout the lawsuit's lifecycle.

Key Dates and Deadlines

One significant deadline approaching is August 25, 2025, which marks the last day for potential lead plaintiffs to register. Hims shareholders should take note and not delay in gathering relevant information and submitting claims. The firm has made the registration process easy through a dedicated form accessible on their website.

Why Join The Gross Law Firm?

The Gross Law Firm stands out as a nationally recognized law firm specializing in class action lawsuits. Their track record reflects a commitment to safeguarding investor rights who have suffered losses due to deceitful business practices. By holding companies accountable for misleading claims, they aim to ensure companies maintain ethical standards in business operations. The firm promises there won’t be any costs or obligations for participating shareholders.

Next Steps

Shareholders who believe they meet the eligibility criteria are encouraged to act swiftly. By registering, investors will be enrolled in portfolio monitoring software that updates them on the case's status. This monitoring service ensures shareholders remain informed as developments unfold.

Contact Information

For those interested, more details and contact forms are available via The Gross Law Firm’s website. Shareholders may also reach the firm directly at their Manhattan offices or via email and phone.

To contact The Gross Law Firm:

- Address: 15 West 38th Street, 12th Floor, New York, NY, 10018
- Email: info@grosslawfirm.com
- Phone: (646) 453-8903

Investors affected by the misleading practices of Hims & Hers Health, Inc. should not miss this opportunity to partake in the recovery process. With The Gross Law Firm’s expertise, shareholders can take proactive measures to protect their financial interests and seek justice for any provided inaccuracies by the company.